ENTITY
Shanghai Junshi Biosciences

Shanghai Junshi Biosciences (1877 HK)

220
Analysis
Health CareChina
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
bullishTencent Music
08 Dec 2018 18:42

Last Week's GER IPO Research: Tencent Music, Softbank, Weimob, Luzhou, Junshi, Yancoal and Asiainfo

We had another busy week for IPO research the GER team. This week, we recommend participating in the Tencent Music Entertainment (TME US) IPO,...

Logo
502 Views
Share
03 Dec 2018 10:11

Junshi Bioscience (君实医药) IPO: Thoughts on Valuation (Part 2)

Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...

Logo
656 Views
Share
03 Dec 2018 08:00

Junshi Biosciences IPO Preview: A Sense of Déjà Vu Without the Excitement

Shanghai Junshi Bioscience Co. Ltd. (1387344D CH) is a biopharmaceutical company which is developing a pipeline of 13 biologic drugs, including...

Logo
420 Views
Share
bullishSoftbank Corp
01 Dec 2018 17:34

ECM Weekly (1 December 2018) - Softbank Corp, Tencent Music, Cansino, Wuxi Apptec, Fosun Tourism

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
12 Nov 2018 09:54

Junshi Bioscience (君实医药) IPO: Early in Application but Behind in Key Indications (Part 1)

Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...

Logo
487 Views
Share
x